They might act as etiological and/or facilitating factors in hyperaldosteronism, both in the presence (i.e., secondary aldosteronism) and the absence of overt activation of the renin–angiotensin system (i.e., primary aldosteronism), since PFAS markedly potentiate the action of Ang II. The gene discussed is AGT; the disease is primary aldosteronism.